Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-18-143615
Filing Date
2018-04-30
Accepted
2018-04-30 17:06:05
Documents
14
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 10-K/A d510931d10ka.htm 10-K/A 1279645
2 EX-31.1 d510931dex311.htm EX-31.1 2706
3 EX-31.2 d510931dex312.htm EX-31.2 2712
4 GRAPHIC g510931g15x48.jpg GRAPHIC 11833
5 GRAPHIC g510931g24c18.jpg GRAPHIC 11102
6 GRAPHIC g510931g52v64.jpg GRAPHIC 35933
7 GRAPHIC g510931g53d84.jpg GRAPHIC 40881
8 GRAPHIC g510931g56z21.jpg GRAPHIC 57019
9 GRAPHIC g510931g62p60.jpg GRAPHIC 12044
10 GRAPHIC g510931g79q85.jpg GRAPHIC 11099
11 GRAPHIC g510931g81q12.jpg GRAPHIC 54456
12 GRAPHIC g510931g83u52.jpg GRAPHIC 12380
13 GRAPHIC g510931g87y55.jpg GRAPHIC 57191
14 GRAPHIC g510931g94p81.jpg GRAPHIC 94917
  Complete submission text file 0001193125-18-143615.txt   1837219
Mailing Address BUILDING 4, TRIDENT PLACE, MOSQUITO WAY HATFIELD, HERTFORDSHIRE X0 AL10 9UL
Business Address BUILDING 4, TRIDENT PLACE, MOSQUITO WAY HATFIELD, HERTFORDSHIRE X0 AL10 9UL 44 0 1707 853 000
Mylan N.V. (Filer) CIK: 0001623613 (see all company filings)

EIN.: 981189497 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 333-199861 | Film No.: 18791028
SIC: 2834 Pharmaceutical Preparations